The global cell separation market size was valued at USD 9.74 billion in 2024 and is projected to reach from USD 10.69 ...

International collaborations, refined gene-editing protocols, and targeted immunologic maneuvers keep the cancer gene therapy ...

Scientists say identification of two epigenetically different states in mouse model opens door to "entirely new world of ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

Research finds no overall difference in cancer risk between red and white wine, but white wine is linked to higher cancer ...

D tumoroid models transform cancer research, accurately reflecting tumor biology and enabling effective drug testing and ...

A miRNA multi-omics study reveals not only mechanisms for miRNA dysregulation, but also the tumor heterogeneity and ... nucleatum in colorectal cancer cells and provides clues to malignant ...

To create one of the most advanced immunotherapies in cancer, CAR-T cell therapies, scientists engineer immune T cells to carry a synthetic protein on their surfaces. This protein, called the ...

Intratumor heterogeneity (ITH) is associated with tumor progression ... Methods: We obtained clinical information and gene expression data for COAD patients from The Cancer Genome Atlas (TCGA) ...

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...

Alterations in the expression and activity of specific translation factors, and the uncoupling of translational regulation from inhibition by tumour cell stresses, such as hypoxia and nutrient ...

Researchers investigated immune-related adverse effects and characteristics that may predict their incidence in patients receiving ICIs for gastrointestinal cancers.